Final S&P Global US Services PMI for June due in 10 minutes.

Morgan Stanley said after consolidating DongYao Pharma’s Q2 2026 results it cut 2026–30 earnings forecasts for 02268.HK by about 0–7%, citing lower gross margins, incremental finance costs and FX losses from USD/RMB depreciation. It lowered its target price to HK$80 from HK$83 and kept an Overweight rating.

TF International Securities analyst Ming‑Chi Kuo says his supply‑chain survey shows foldable iPhone assembly shipments of about 7–8 million in H2 2026, with Q3 shipments of 0.5–1.0 million (around 10% of H2). By contrast, iPhone 18 Pro/Pro Max are estimated at about 20–22 million in Q3 and are already stocked for a September retail launch. Kuo says, based on Q3 stocking, the foldable model is likely to mirror the 2017 iPhone X pattern — announced with other models but opening pre‑orders and official sales later — and expects supply tightness to persist through year‑end.